Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
other: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study with acceptable restrictions
Remarks:
Source study has reliability 2. Details on the read across are attached in section13.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1993
Report date:
1993

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Qualifier:
according to guideline
Guideline:
EU Method B.1 (Acute Toxicity (Oral))
Qualifier:
according to guideline
Guideline:
other: WHO/VBC 88.953
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Reference substance name:
Similar Substance 01
IUPAC Name:
Similar Substance 01
Test material form:
solid: particulate/powder

Test animals

Species:
rat
Strain:
other: TIf: RAI f (SPF)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: CIBA-GEIGY Limited Animal Production 4332 Stein / Switzerland
- Weight at study initiation: 177 to 206 g
- Fasting period before study: overnight
- Housing: in Macrolon cages type 4, with standardized soft wood beeding
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 2 °C
- Humidity: 55 ± 10 %
- Air changes: 15 per h
- Photoperiod: 12 h /day light cycle.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
Single oral dose, by gastric intubation (gavage)
Vehicle: distilled water
Amount of vehicle: 10 ml/kg bw

Doses:
2000 mg/kg (males and females)
Volume applied: 10 ml/kg bw
No. of animals per sex per dose:
5 males and 5 females (total number of animals: 10)
Control animals:
yes
Details on study design:
Observations and records
Mortality: daily; a.m. and p.m. on working days, a.m. on weekend days.
Signs and symptoms: daily for 14 days.
Body weight: immediately before administration and on days 7 and 14.
Necropsies: animals submitted to a gross necropsy at the end of the observation period.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortalities occurred.
Clinical signs:
other: Piloerection, hunched posture, and dyspnea were seen, being common symptoms in acute tests. Additionally, diarrhea was observed in females. Animals recovered within 5 days.
Gross pathology:
At necropsy, a spotted thymus was found in one female. No deviations from normal morphology were found in the remaining animals.

Any other information on results incl. tables






















                         dose (mg/kg)number of animalsnumber of deaths
males200050
famales200050

 

Applicant's summary and conclusion

Interpretation of results:
other: not classified, according to the CLP Regulation (EC 1272/2008)
Conclusions:
The substance was tested according to the guidelines OECD 401.
Upon an acute oral administration and a 14 day post-treatment observation period in rats of both sexes, no mortality was recorded. Therefore, in male and female rats:
LD0 = 2000 mg/kg
LD50 > 2000 mg/kg
Executive summary:

Method

Acute oral toxicity to rats was assessed in a limit test. A single dose of 2000 mg/kg was given by gavage to 10 young adult rats (5 males and 5 females Tif: Rai f). Rats were obserevd daily for 14 days after dosing. Mortality, signs and symptoms were recorded daily; body weight was measured immediately before administration and on days 7 and 14; necropsy was done at the end of the observation period.

Results

No mortality was seen during the 14 -days observation period, thus LD0 = 2000 mg/kg and LD50 > 2000 mg/kg.

Clinical signs as piloerection, dyspnea, hunched posture and diarrhea were recorded.